Cargando…

Theophylline is able to partially revert cachexia in tumour-bearing rats

BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submit...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivan, Mireia, Springer, Jochen, Busquets, Sílvia, Tschirner, Anika, Figueras, Maite, Toledo, Miriam, Fontes-Oliveira, Cibely, Genovese, Maria Inés, Ventura da Silva, Paula, Sette, Angelica, López-Soriano, Francisco J, Anker, Stefan, Argilés, Josep M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495887/
https://www.ncbi.nlm.nih.gov/pubmed/22909172
http://dx.doi.org/10.1186/1743-7075-9-76
_version_ 1782249585040687104
author Olivan, Mireia
Springer, Jochen
Busquets, Sílvia
Tschirner, Anika
Figueras, Maite
Toledo, Miriam
Fontes-Oliveira, Cibely
Genovese, Maria Inés
Ventura da Silva, Paula
Sette, Angelica
López-Soriano, Francisco J
Anker, Stefan
Argilés, Josep M
author_facet Olivan, Mireia
Springer, Jochen
Busquets, Sílvia
Tschirner, Anika
Figueras, Maite
Toledo, Miriam
Fontes-Oliveira, Cibely
Genovese, Maria Inés
Ventura da Silva, Paula
Sette, Angelica
López-Soriano, Francisco J
Anker, Stefan
Argilés, Josep M
author_sort Olivan, Mireia
collection PubMed
description BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. RESULTS: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. CONCLUSION: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia.
format Online
Article
Text
id pubmed-3495887
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34958872012-11-13 Theophylline is able to partially revert cachexia in tumour-bearing rats Olivan, Mireia Springer, Jochen Busquets, Sílvia Tschirner, Anika Figueras, Maite Toledo, Miriam Fontes-Oliveira, Cibely Genovese, Maria Inés Ventura da Silva, Paula Sette, Angelica López-Soriano, Francisco J Anker, Stefan Argilés, Josep M Nutr Metab (Lond) Research BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. RESULTS: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. CONCLUSION: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia. BioMed Central 2012-08-21 /pmc/articles/PMC3495887/ /pubmed/22909172 http://dx.doi.org/10.1186/1743-7075-9-76 Text en Copyright ©2012 Olivan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Olivan, Mireia
Springer, Jochen
Busquets, Sílvia
Tschirner, Anika
Figueras, Maite
Toledo, Miriam
Fontes-Oliveira, Cibely
Genovese, Maria Inés
Ventura da Silva, Paula
Sette, Angelica
López-Soriano, Francisco J
Anker, Stefan
Argilés, Josep M
Theophylline is able to partially revert cachexia in tumour-bearing rats
title Theophylline is able to partially revert cachexia in tumour-bearing rats
title_full Theophylline is able to partially revert cachexia in tumour-bearing rats
title_fullStr Theophylline is able to partially revert cachexia in tumour-bearing rats
title_full_unstemmed Theophylline is able to partially revert cachexia in tumour-bearing rats
title_short Theophylline is able to partially revert cachexia in tumour-bearing rats
title_sort theophylline is able to partially revert cachexia in tumour-bearing rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495887/
https://www.ncbi.nlm.nih.gov/pubmed/22909172
http://dx.doi.org/10.1186/1743-7075-9-76
work_keys_str_mv AT olivanmireia theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT springerjochen theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT busquetssilvia theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT tschirneranika theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT figuerasmaite theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT toledomiriam theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT fontesoliveiracibely theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT genovesemariaines theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT venturadasilvapaula theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT setteangelica theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT lopezsorianofranciscoj theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT ankerstefan theophyllineisabletopartiallyrevertcachexiaintumourbearingrats
AT argilesjosepm theophyllineisabletopartiallyrevertcachexiaintumourbearingrats